Table 3.
PC | CP | P value | |
---|---|---|---|
Lin-HLA-DR- | 57.3 (9.4–90.9)* | 91.82 (10.6–95.8)* | 0.07 |
Lin-HLA-DR-CD33+11b+ | 2.9 (1.4–27.6)* | 0.35 (0.03–13.7)* | 0.48 |
Lin-HLA-DR-CD33+11b+CD15+ | 11.1 (0.5–72.3)* | 0.2 (0–45.1)* | 0.037 |
Lin-HLA-DR-CD14+ | 2.5 (0.19–5.07)* | 0.3 (0.1–17.5)* | 0.66 |
HLA-DR-/lowCD14+ | 2.7 (0.5–5.1)* | 2.3 (0–14.1)* | 0.62 |
HLA-DR-/LowCD33+ | 6.9 (0.82–25.5)* | 11.5 (0.31–13.6)* | 0.82 |
PC: pancreatic cancer; CP: chronic pancreatitis; HDs: healthy donors.*Data shown represent median (range). The bold values refer to statistically significant P values.